JP2020513041A - 病原体の阻害および/または粘液の改変のための化合物、組成物、および方法 - Google Patents
病原体の阻害および/または粘液の改変のための化合物、組成物、および方法 Download PDFInfo
- Publication number
- JP2020513041A JP2020513041A JP2020504468A JP2020504468A JP2020513041A JP 2020513041 A JP2020513041 A JP 2020513041A JP 2020504468 A JP2020504468 A JP 2020504468A JP 2020504468 A JP2020504468 A JP 2020504468A JP 2020513041 A JP2020513041 A JP 2020513041A
- Authority
- JP
- Japan
- Prior art keywords
- mucus
- releasing
- biopolymer
- releasing biopolymer
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483655P | 2017-04-10 | 2017-04-10 | |
| US62/483,655 | 2017-04-10 | ||
| PCT/IB2018/052522 WO2018189687A1 (en) | 2017-04-10 | 2018-04-10 | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020513041A true JP2020513041A (ja) | 2020-04-30 |
| JP2020513041A5 JP2020513041A5 (enExample) | 2021-05-20 |
Family
ID=63792445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504468A Pending JP2020513041A (ja) | 2017-04-10 | 2018-04-10 | 病原体の阻害および/または粘液の改変のための化合物、組成物、および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11324773B2 (enExample) |
| EP (1) | EP3592335A4 (enExample) |
| JP (1) | JP2020513041A (enExample) |
| CN (1) | CN110573143A (enExample) |
| WO (1) | WO2018189687A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018236803A1 (en) | 2017-06-19 | 2018-12-27 | Novan, Inc. | Topical compositions and methods of using the same |
| WO2019169221A1 (en) | 2018-03-01 | 2019-09-06 | Novan, Inc. | Nitric oxide releasing suppositories and methods of use thereof |
| CN115486478A (zh) * | 2022-10-09 | 2022-12-20 | 江苏天美健大自然生物工程有限公司 | 一种蛋白饮料用防腐剂组合物及其制备方法 |
| WO2025049608A1 (en) * | 2023-08-28 | 2025-03-06 | Calroyhealth Sciences, Llc | Compositions and methods to protect and enhance structural and functional integrity of the intestinal glycocalyx |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234933A (en) | 1991-10-31 | 1993-08-10 | Board Of Governors Of Wayne State University And Vanderbilt University | Cyclic hydroxamic acids |
| DE4210332C1 (enExample) | 1992-03-30 | 1993-07-15 | Gruenenthal Gmbh, 5100 Aachen, De | |
| US5238832A (en) | 1992-06-08 | 1993-08-24 | Board Of Governors Of Wayne State University | Aryl aliphatic acids |
| EP0768875A1 (en) | 1994-07-14 | 1997-04-23 | The Wellcome Foundation Limited | Nitric oxide synthase inhibitors for inhibiting the production of airway mucus |
| US6180082B1 (en) | 1997-11-24 | 2001-01-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Method to enhance tissue accumulation of radiolabeled compounds |
| US6261594B1 (en) | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
| IT1303793B1 (it) * | 1998-11-27 | 2001-02-23 | Promefarm S R L | "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)" |
| CA2565230A1 (en) * | 2004-05-11 | 2005-11-24 | Pulmonox Technologies Corporation | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
| US8399005B2 (en) | 2007-10-12 | 2013-03-19 | University Of North Carolina At Chapel Hill | Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents |
| GB201021186D0 (en) | 2010-12-14 | 2011-01-26 | Novabiotics Ltd | Composition |
| JP6298818B2 (ja) * | 2012-08-17 | 2018-03-20 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 水溶性一酸化窒素放出ポリグルコサミンおよびそれらの使用 |
-
2018
- 2018-04-10 CN CN201880024184.1A patent/CN110573143A/zh active Pending
- 2018-04-10 JP JP2020504468A patent/JP2020513041A/ja active Pending
- 2018-04-10 WO PCT/IB2018/052522 patent/WO2018189687A1/en not_active Ceased
- 2018-04-10 EP EP18784598.7A patent/EP3592335A4/en active Pending
- 2018-04-10 US US16/500,755 patent/US11324773B2/en active Active
Non-Patent Citations (1)
| Title |
|---|
| BIOFOULING, vol. 31, JPN6022013272, 2015, ISSN: 0004843318 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3592335A4 (en) | 2021-01-27 |
| US20200085858A1 (en) | 2020-03-19 |
| WO2018189687A1 (en) | 2018-10-18 |
| US11324773B2 (en) | 2022-05-10 |
| EP3592335A1 (en) | 2020-01-15 |
| CN110573143A (zh) | 2019-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106986952B (zh) | 水溶性的释放一氧化氮的聚葡糖胺和其用途 | |
| US11697693B2 (en) | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto | |
| US12398092B2 (en) | Method for inhibiting or disrupting biofilm formation, or reducing biofilm | |
| Francesko et al. | Bacteria-responsive multilayer coatings comprising polycationic nanospheres for bacteria biofilm prevention on urinary catheters | |
| US9187501B2 (en) | Nitric oxide-releasing nanorods and their methods of use | |
| Lu et al. | Hyaluronic acid-based levofloxacin nanomicelles for nitric oxide-triggered drug delivery to treat bacterial infections | |
| US11324773B2 (en) | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus | |
| US20210393855A1 (en) | New hydrogels having a silylated structure, and method for obtaining same | |
| Kulshrestha | Nanoparticle induced suppression of microbial biofilm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210405 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210405 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220405 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220627 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220804 |